Actuate Therapeutics, Inc IPOs Tomorrow, Here's What You Need To Know
Actuate Therapeutics, Inc IPOs Tomorrow, Here's What You Need To Know
Actuate Therapeutics, Inc (NASDAQ:ACTU) IPO will take place July, 24 on the NASDAQ exchange under the ticker ACTU.
Actuate Therapeutics, Inc（纳斯达克代码：ACTU）的首次公开募股将于7月24日在纳斯达克交易所的逐笔明细下进行。
The company is offering shares at an expected price between $8.00 and $10.00 per share with an insider lock-up period of 180 days ending on January 20, 2025.
该公司推出股票，每股预计价格在8.00美元至10.00美元之间，内部人士锁定期为180天，截止日期为2025年1月20日。
See also: Benzinga IPO Calendar
参见：Benzinga IPO日历
About Actuate Therapeutics, Inc
关于Actuate Therapeutics, Inc
Actuate Therapeutics, Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3
Actuate Therapeutics，Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合成酶激酶-3的活性，开发治疗高影响力难治性癌症的疗法。
See also: Benzinga's Most Shorted Stocks
参见：Benzinga的做空集合股
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动化内容引擎生成并由编辑审查。